U.S. markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
9.75-0.11 (-1.12%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
16,673,000
16,887,000
18,854,000
22,385,000
21,903,000
Cost of Revenue
9,038,000
9,351,000
10,558,000
11,560,000
10,044,000
Gross Profit
7,636,000
7,537,000
8,296,000
10,825,000
11,859,000
Operating Expense
4,600,000
4,794,000
5,407,000
6,812,000
7,207,000
Operating Income
3,036,000
2,743,000
2,889,000
4,013,000
4,652,000
Net Non Operating Interest Income Expense
-807,000
-877,000
-985,000
-872,000
-548,000
Other Income Expense
-6,808,000
-3,130,000
-4,500,000
-21,520,000
-3,280,000
Pretax Income
-4,582,000
-1,265,000
-2,596,000
-18,379,000
824,000
Tax Provision
-266,000
-278,000
-195,000
-1,933,000
521,000
Earnings from Equity Interest Net of Tax
130,000
-13,000
-71,000
-3,000
8,000
Net Income Common Stockholders
-4,031,000
-999,000
-2,399,000
-16,525,000
68,000
Diluted NI Available to Com Stockholders
-4,031,000
-999,000
-2,399,000
-16,525,000
68,000
Basic EPS
-
0
-0.0024
-0.0163
0
Diluted EPS
-
0
-0.0024
-0.0163
0
Basic Average Shares
-
1,091,000
1,021,000
1,016,000
955,000
Diluted Average Shares
-
1,091,000
1,021,000
1,016,000
961,000
Total Operating Income as Reported
-3,830,000
-443,000
-1,637,000
-17,484,000
2,154,000
Total Expenses
13,638,000
14,145,000
15,965,000
18,372,000
17,251,000
Net Income from Continuing & Discontinued Operation
-4,031,000
-999,000
-2,150,000
-16,265,000
329,000
Normalized Income
2,435,464
1,443,142
1,990,000
2,887,800
2,789,000
Interest Expense
811,000
881,000
920,000
875,000
546,000
Net Interest Income
-807,000
-877,000
-985,000
-872,000
-548,000
EBIT
-3,771,000
-384,000
-1,676,000
-17,504,000
1,370,000
EBITDA
-2,193,000
-
-
-
-
Reconciled Cost of Revenue
9,038,000
9,351,000
10,558,000
11,560,000
10,044,000
Reconciled Depreciation
1,578,000
1,722,000
1,842,000
2,112,000
1,524,000
Net Income from Continuing Operation Net Minority Interest
-4,031,000
-999,000
-2,150,000
-16,265,000
329,000
Total Unusual Items Excluding Goodwill
-6,865,000
-3,130,000
-4,500,000
-21,520,000
-3,280,000
Total Unusual Items
-6,865,000
-3,130,000
-4,500,000
-21,520,000
-3,280,000
Normalized EBITDA
4,672,000
4,468,000
4,666,000
6,128,000
6,174,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-398,536
-687,858
-360,000
-2,367,200
-820,000